Global Gastrointestinal Therapeutics Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
Gastrointestinal disorders are medical conditions related to the digestive system that affect the colon, small & large intestine, and rectum. The disorders mainly include constipation, peptic ulcer diseases, and irritable bowel syndrome characterized by various symptoms such as pain, bloating, diarrhea, nausea, and vomiting. Gastrointestinal therapeutics includes drugs, which are commercially available in the market namely Aciphex, Afinitor, Akynzeo, Dificid, and Prilosec.
SCOPE OF THE REPORT:
This report studies the Gastrointestinal Therapeutics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Gastrointestinal Therapeutics market by product type and applications/end industries.
Accounting for more than 80% of the total market shares, the IBD disease market segment dominated the market. IBD involves a group of autoimmune diseases such as Crohn's disease and ulcerative colitis and is expected to grow at a CAGR of more than 4.3% in the next few years.
In terms of geographical regions, the Americas will account for almost 50% of the total market shares and will also be the major revenue contributor to the gastrointestinal therapeutics market throughout the forecast period. The rising acceptance of biologics and the introduction of healthcare reforms by various countries in the region will augment the market?s growth prospects in the next few years.
The global Gastrointestinal Therapeutics market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Gastrointestinal Therapeutics.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
SCOPE OF THE REPORT:
This report studies the Gastrointestinal Therapeutics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Gastrointestinal Therapeutics market by product type and applications/end industries.
Accounting for more than 80% of the total market shares, the IBD disease market segment dominated the market. IBD involves a group of autoimmune diseases such as Crohn's disease and ulcerative colitis and is expected to grow at a CAGR of more than 4.3% in the next few years.
In terms of geographical regions, the Americas will account for almost 50% of the total market shares and will also be the major revenue contributor to the gastrointestinal therapeutics market throughout the forecast period. The rising acceptance of biologics and the introduction of healthcare reforms by various countries in the region will augment the market?s growth prospects in the next few years.
The global Gastrointestinal Therapeutics market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Gastrointestinal Therapeutics.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
- AbbVie
- Allergan
- Johnson & Johnson
- Takeda
- Novartis
- Pfizer
- Merck
- F. Hoffmann-La Roche
- Eli Lilly
- AstraZeneca
- Procter & Gamble
- Tillotts Pharma
- Shire Pharmaceuticals
- GlaxoSmithKline
- Amgen
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
- Oral
- Parenteral
- IBD
- Irritable Bowel Syndrome (IBS)
1 GASTROINTESTINAL THERAPEUTICS MARKET OVERVIEW
1.1 Product Overview and Scope of Gastrointestinal Therapeutics
1.2 Classification of Gastrointestinal Therapeutics by Types
1.2.1 Global Gastrointestinal Therapeutics Revenue Comparison by Types (2017-2023)
1.2.2 Global Gastrointestinal Therapeutics Revenue Market Share by Types in 2017
1.2.3 Oral
1.2.4 Parenteral
1.3 Global Gastrointestinal Therapeutics Market by Application
1.3.1 Global Gastrointestinal Therapeutics Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 IBD
1.3.3 Irritable Bowel Syndrome (IBS)
1.4 Global Gastrointestinal Therapeutics Market by Regions
1.4.1 Global Gastrointestinal Therapeutics Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Gastrointestinal Therapeutics Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Gastrointestinal Therapeutics Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Gastrointestinal Therapeutics Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Gastrointestinal Therapeutics Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Gastrointestinal Therapeutics Status and Prospect (2013-2023)
1.5 Global Market Size of Gastrointestinal Therapeutics (2013-2023)
2 MANUFACTURERS PROFILES
2.1 AbbVie
2.1.1 Business Overview
2.1.2 Gastrointestinal Therapeutics Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 AbbVie Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.2 Allergan
2.2.1 Business Overview
2.2.2 Gastrointestinal Therapeutics Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Allergan Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.3 Johnson & Johnson
2.3.1 Business Overview
2.3.2 Gastrointestinal Therapeutics Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Johnson & Johnson Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.4 Takeda
2.4.1 Business Overview
2.4.2 Gastrointestinal Therapeutics Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Takeda Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.5 Novartis
2.5.1 Business Overview
2.5.2 Gastrointestinal Therapeutics Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Novartis Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.6 Pfizer
2.6.1 Business Overview
2.6.2 Gastrointestinal Therapeutics Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Pfizer Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.7 Merck
2.7.1 Business Overview
2.7.2 Gastrointestinal Therapeutics Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Merck Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.8 F. Hoffmann-La Roche
2.8.1 Business Overview
2.8.2 Gastrointestinal Therapeutics Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 F. Hoffmann-La Roche Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.9 Eli Lilly
2.9.1 Business Overview
2.9.2 Gastrointestinal Therapeutics Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Eli Lilly Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.10 AstraZeneca
2.10.1 Business Overview
2.10.2 Gastrointestinal Therapeutics Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 AstraZeneca Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.11 Procter & Gamble
2.11.1 Business Overview
2.11.2 Gastrointestinal Therapeutics Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Procter & Gamble Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.12 Tillotts Pharma
2.12.1 Business Overview
2.12.2 Gastrointestinal Therapeutics Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Tillotts Pharma Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.13 Shire Pharmaceuticals
2.13.1 Business Overview
2.13.2 Gastrointestinal Therapeutics Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Shire Pharmaceuticals Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.14 GlaxoSmithKline
2.14.1 Business Overview
2.14.2 Gastrointestinal Therapeutics Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 GlaxoSmithKline Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.15 Amgen
2.15.1 Business Overview
2.15.2 Gastrointestinal Therapeutics Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Amgen Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
3 GLOBAL GASTROINTESTINAL THERAPEUTICS MARKET COMPETITION, BY PLAYERS
3.1 Global Gastrointestinal Therapeutics Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Gastrointestinal Therapeutics Players Market Share
3.2.2 Top 10 Gastrointestinal Therapeutics Players Market Share
3.3 Market Competition Trend
4 GLOBAL GASTROINTESTINAL THERAPEUTICS MARKET SIZE BY REGIONS
4.1 Global Gastrointestinal Therapeutics Revenue and Market Share by Regions
4.2 North America Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
4.3 Europe Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
4.5 South America Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
5 NORTH AMERICA GASTROINTESTINAL THERAPEUTICS REVENUE BY COUNTRIES
5.1 North America Gastrointestinal Therapeutics Revenue by Countries (2013-2018)
5.2 USA Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
5.3 Canada Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
5.4 Mexico Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
6 EUROPE GASTROINTESTINAL THERAPEUTICS REVENUE BY COUNTRIES
6.1 Europe Gastrointestinal Therapeutics Revenue by Countries (2013-2018)
6.2 Germany Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
6.3 UK Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
6.4 France Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
6.5 Russia Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
6.6 Italy Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
7 ASIA-PACIFIC GASTROINTESTINAL THERAPEUTICS REVENUE BY COUNTRIES
7.1 Asia-Pacific Gastrointestinal Therapeutics Revenue by Countries (2013-2018)
7.2 China Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
7.3 Japan Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
7.4 Korea Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
7.5 India Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
8 SOUTH AMERICA GASTROINTESTINAL THERAPEUTICS REVENUE BY COUNTRIES
8.1 South America Gastrointestinal Therapeutics Revenue by Countries (2013-2018)
8.2 Brazil Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
8.3 Argentina Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
8.4 Colombia Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
9 MIDDLE EAST AND AFRICA REVENUE GASTROINTESTINAL THERAPEUTICS BY COUNTRIES
9.1 Middle East and Africa Gastrointestinal Therapeutics Revenue by Countries (2013-2018)
9.2 Saudi Arabia Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
9.3 UAE Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
9.4 Egypt Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
9.5 Nigeria Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
9.6 South Africa Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
10 GLOBAL GASTROINTESTINAL THERAPEUTICS MARKET SEGMENT BY TYPE
10.1 Global Gastrointestinal Therapeutics Revenue and Market Share by Type (2013-2018)
10.2 Global Gastrointestinal Therapeutics Market Forecast by Type (2018-2023)
10.3 Oral Revenue Growth Rate (2013-2023)
10.4 Parenteral Revenue Growth Rate (2013-2023)
11 GLOBAL GASTROINTESTINAL THERAPEUTICS MARKET SEGMENT BY APPLICATION
11.1 Global Gastrointestinal Therapeutics Revenue Market Share by Application (2013-2018)
11.2 Gastrointestinal Therapeutics Market Forecast by Application (2018-2023)
11.3 IBD Revenue Growth (2013-2018)
11.4 Irritable Bowel Syndrome (IBS) Revenue Growth (2013-2018)
12 GLOBAL GASTROINTESTINAL THERAPEUTICS MARKET SIZE FORECAST (2018-2023)
12.1 Global Gastrointestinal Therapeutics Market Size Forecast (2018-2023)
12.2 Global Gastrointestinal Therapeutics Market Forecast by Regions (2018-2023)
12.3 North America Gastrointestinal Therapeutics Revenue Market Forecast (2018-2023)
12.4 Europe Gastrointestinal Therapeutics Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Gastrointestinal Therapeutics Revenue Market Forecast (2018-2023)
12.6 South America Gastrointestinal Therapeutics Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Gastrointestinal Therapeutics Revenue Market Forecast (2018-2023)
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Data Source
1.1 Product Overview and Scope of Gastrointestinal Therapeutics
1.2 Classification of Gastrointestinal Therapeutics by Types
1.2.1 Global Gastrointestinal Therapeutics Revenue Comparison by Types (2017-2023)
1.2.2 Global Gastrointestinal Therapeutics Revenue Market Share by Types in 2017
1.2.3 Oral
1.2.4 Parenteral
1.3 Global Gastrointestinal Therapeutics Market by Application
1.3.1 Global Gastrointestinal Therapeutics Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 IBD
1.3.3 Irritable Bowel Syndrome (IBS)
1.4 Global Gastrointestinal Therapeutics Market by Regions
1.4.1 Global Gastrointestinal Therapeutics Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Gastrointestinal Therapeutics Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Gastrointestinal Therapeutics Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Gastrointestinal Therapeutics Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Gastrointestinal Therapeutics Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Gastrointestinal Therapeutics Status and Prospect (2013-2023)
1.5 Global Market Size of Gastrointestinal Therapeutics (2013-2023)
2 MANUFACTURERS PROFILES
2.1 AbbVie
2.1.1 Business Overview
2.1.2 Gastrointestinal Therapeutics Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 AbbVie Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.2 Allergan
2.2.1 Business Overview
2.2.2 Gastrointestinal Therapeutics Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Allergan Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.3 Johnson & Johnson
2.3.1 Business Overview
2.3.2 Gastrointestinal Therapeutics Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Johnson & Johnson Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.4 Takeda
2.4.1 Business Overview
2.4.2 Gastrointestinal Therapeutics Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Takeda Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.5 Novartis
2.5.1 Business Overview
2.5.2 Gastrointestinal Therapeutics Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Novartis Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.6 Pfizer
2.6.1 Business Overview
2.6.2 Gastrointestinal Therapeutics Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Pfizer Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.7 Merck
2.7.1 Business Overview
2.7.2 Gastrointestinal Therapeutics Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Merck Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.8 F. Hoffmann-La Roche
2.8.1 Business Overview
2.8.2 Gastrointestinal Therapeutics Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 F. Hoffmann-La Roche Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.9 Eli Lilly
2.9.1 Business Overview
2.9.2 Gastrointestinal Therapeutics Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Eli Lilly Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.10 AstraZeneca
2.10.1 Business Overview
2.10.2 Gastrointestinal Therapeutics Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 AstraZeneca Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.11 Procter & Gamble
2.11.1 Business Overview
2.11.2 Gastrointestinal Therapeutics Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Procter & Gamble Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.12 Tillotts Pharma
2.12.1 Business Overview
2.12.2 Gastrointestinal Therapeutics Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Tillotts Pharma Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.13 Shire Pharmaceuticals
2.13.1 Business Overview
2.13.2 Gastrointestinal Therapeutics Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Shire Pharmaceuticals Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.14 GlaxoSmithKline
2.14.1 Business Overview
2.14.2 Gastrointestinal Therapeutics Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 GlaxoSmithKline Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.15 Amgen
2.15.1 Business Overview
2.15.2 Gastrointestinal Therapeutics Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Amgen Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
3 GLOBAL GASTROINTESTINAL THERAPEUTICS MARKET COMPETITION, BY PLAYERS
3.1 Global Gastrointestinal Therapeutics Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Gastrointestinal Therapeutics Players Market Share
3.2.2 Top 10 Gastrointestinal Therapeutics Players Market Share
3.3 Market Competition Trend
4 GLOBAL GASTROINTESTINAL THERAPEUTICS MARKET SIZE BY REGIONS
4.1 Global Gastrointestinal Therapeutics Revenue and Market Share by Regions
4.2 North America Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
4.3 Europe Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
4.5 South America Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
5 NORTH AMERICA GASTROINTESTINAL THERAPEUTICS REVENUE BY COUNTRIES
5.1 North America Gastrointestinal Therapeutics Revenue by Countries (2013-2018)
5.2 USA Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
5.3 Canada Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
5.4 Mexico Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
6 EUROPE GASTROINTESTINAL THERAPEUTICS REVENUE BY COUNTRIES
6.1 Europe Gastrointestinal Therapeutics Revenue by Countries (2013-2018)
6.2 Germany Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
6.3 UK Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
6.4 France Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
6.5 Russia Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
6.6 Italy Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
7 ASIA-PACIFIC GASTROINTESTINAL THERAPEUTICS REVENUE BY COUNTRIES
7.1 Asia-Pacific Gastrointestinal Therapeutics Revenue by Countries (2013-2018)
7.2 China Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
7.3 Japan Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
7.4 Korea Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
7.5 India Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
8 SOUTH AMERICA GASTROINTESTINAL THERAPEUTICS REVENUE BY COUNTRIES
8.1 South America Gastrointestinal Therapeutics Revenue by Countries (2013-2018)
8.2 Brazil Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
8.3 Argentina Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
8.4 Colombia Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
9 MIDDLE EAST AND AFRICA REVENUE GASTROINTESTINAL THERAPEUTICS BY COUNTRIES
9.1 Middle East and Africa Gastrointestinal Therapeutics Revenue by Countries (2013-2018)
9.2 Saudi Arabia Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
9.3 UAE Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
9.4 Egypt Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
9.5 Nigeria Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
9.6 South Africa Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
10 GLOBAL GASTROINTESTINAL THERAPEUTICS MARKET SEGMENT BY TYPE
10.1 Global Gastrointestinal Therapeutics Revenue and Market Share by Type (2013-2018)
10.2 Global Gastrointestinal Therapeutics Market Forecast by Type (2018-2023)
10.3 Oral Revenue Growth Rate (2013-2023)
10.4 Parenteral Revenue Growth Rate (2013-2023)
11 GLOBAL GASTROINTESTINAL THERAPEUTICS MARKET SEGMENT BY APPLICATION
11.1 Global Gastrointestinal Therapeutics Revenue Market Share by Application (2013-2018)
11.2 Gastrointestinal Therapeutics Market Forecast by Application (2018-2023)
11.3 IBD Revenue Growth (2013-2018)
11.4 Irritable Bowel Syndrome (IBS) Revenue Growth (2013-2018)
12 GLOBAL GASTROINTESTINAL THERAPEUTICS MARKET SIZE FORECAST (2018-2023)
12.1 Global Gastrointestinal Therapeutics Market Size Forecast (2018-2023)
12.2 Global Gastrointestinal Therapeutics Market Forecast by Regions (2018-2023)
12.3 North America Gastrointestinal Therapeutics Revenue Market Forecast (2018-2023)
12.4 Europe Gastrointestinal Therapeutics Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Gastrointestinal Therapeutics Revenue Market Forecast (2018-2023)
12.6 South America Gastrointestinal Therapeutics Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Gastrointestinal Therapeutics Revenue Market Forecast (2018-2023)
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Data Source
LIST OF TABLES AND FIGURES
Figure Gastrointestinal Therapeutics Picture
Table Product Specifications of Gastrointestinal Therapeutics
Table Global Gastrointestinal Therapeutics and Revenue (Million USD) Market Split by Product Type
Figure Global Gastrointestinal Therapeutics Revenue Market Share by Types in 2017
Figure Oral Picture
Figure Parenteral Picture
Table Global Gastrointestinal Therapeutics Revenue (Million USD) by Application (2013-2023)
Figure Gastrointestinal Therapeutics Revenue Market Share by Applications in 2017
Figure IBD Picture
Figure Irritable Bowel Syndrome (IBS) Picture
Table Global Market Gastrointestinal Therapeutics Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Gastrointestinal Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Gastrointestinal Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Gastrointestinal Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Gastrointestinal Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Gastrointestinal Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Gastrointestinal Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Table AbbVie Basic Information, Manufacturing Base and Competitors
Table AbbVie Gastrointestinal Therapeutics Type and Applications
Table AbbVie Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Allergan Basic Information, Manufacturing Base and Competitors
Table Allergan Gastrointestinal Therapeutics Type and Applications
Table Allergan Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Gastrointestinal Therapeutics Type and Applications
Table Johnson & Johnson Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Takeda Basic Information, Manufacturing Base and Competitors
Table Takeda Gastrointestinal Therapeutics Type and Applications
Table Takeda Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Gastrointestinal Therapeutics Type and Applications
Table Novartis Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Gastrointestinal Therapeutics Type and Applications
Table Pfizer Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Gastrointestinal Therapeutics Type and Applications
Table Merck Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table F. Hoffmann-La Roche Basic Information, Manufacturing Base and Competitors
Table F. Hoffmann-La Roche Gastrointestinal Therapeutics Type and Applications
Table F. Hoffmann-La Roche Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Eli Lilly Basic Information, Manufacturing Base and Competitors
Table Eli Lilly Gastrointestinal Therapeutics Type and Applications
Table Eli Lilly Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Gastrointestinal Therapeutics Type and Applications
Table AstraZeneca Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Procter & Gamble Basic Information, Manufacturing Base and Competitors
Table Procter & Gamble Gastrointestinal Therapeutics Type and Applications
Table Procter & Gamble Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Tillotts Pharma Basic Information, Manufacturing Base and Competitors
Table Tillotts Pharma Gastrointestinal Therapeutics Type and Applications
Table Tillotts Pharma Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Shire Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Shire Pharmaceuticals Gastrointestinal Therapeutics Type and Applications
Table Shire Pharmaceuticals Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline Gastrointestinal Therapeutics Type and Applications
Table GlaxoSmithKline Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Amgen Basic Information, Manufacturing Base and Competitors
Table Amgen Gastrointestinal Therapeutics Type and Applications
Table Amgen Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Global Gastrointestinal Therapeutics Revenue (Million USD) by Players (2013-2018)
Table Global Gastrointestinal Therapeutics Revenue Share by Players (2013-2018)
Figure Global Gastrointestinal Therapeutics Revenue Share by Players in 2016
Figure Global Gastrointestinal Therapeutics Revenue Share by Players in 2017
Figure Global Top 5 Players Gastrointestinal Therapeutics Revenue Market Share in 2017
Figure Global Top 10 Players Gastrointestinal Therapeutics Revenue Market Share in 2017
Figure Global Gastrointestinal Therapeutics Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Gastrointestinal Therapeutics Revenue (Million USD) by Regions (2013-2018)
Table Global Gastrointestinal Therapeutics Revenue Market Share by Regions (2013-2018)
Figure Global Gastrointestinal Therapeutics Revenue Market Share by Regions (2013-2018)
Figure Global Gastrointestinal Therapeutics Revenue Market Share by Regions in 2017
Figure North America Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
Figure Europe Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
Figure South America Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
Table North America Gastrointestinal Therapeutics Revenue by Countries (2013-2018)
Table North America Gastrointestinal Therapeutics Revenue Market Share by Countries (2013-2018)
Figure North America Gastrointestinal Therapeutics Revenue Market Share by Countries (2013-2018)
Figure North America Gastrointestinal Therapeutics Revenue Market Share by Countries in 2017
Figure USA Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
Figure Canada Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
Figure Mexico Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
Table Europe Gastrointestinal Therapeutics Revenue (Million USD) by Countries (2013-2018)
Figure Europe Gastrointestinal Therapeutics Revenue Market Share by Countries (2013-2018)
Figure Europe Gastrointestinal Therapeutics Revenue Market Share by Countries in 2017
Figure Germany Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
Figure UK Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
Figure France Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
Figure Russia Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
Figure Italy Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Gastrointestinal Therapeutics Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Gastrointestinal Therapeutics Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Gastrointestinal Therapeutics Revenue Market Share by Countries in 2017
Figure China Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
Figure Japan Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
Figure Korea Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
Figure India Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
Table South America Gastrointestinal Therapeutics Revenue by Countries (2013-2018)
Table South America Gastrointestinal Therapeutics Revenue Market Share by Countries (2013-2018)
Figure South America Gastrointestinal Therapeutics Revenue Market Share by Countries (2013-2018)
Figure South America Gastrointestinal Therapeutics Revenue Market Share by Countries in 2017
Figure Brazil Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
Figure Argentina Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
Figure Colombia Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Gastrointestinal Therapeutics Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Gastrointestinal Therapeutics Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Gastrointestinal Therapeutics Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Gastrointestinal Therapeutics Revenue Market Share by Countries in 2017
Figure Saudi Arabia Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
Figure UAE Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
Figure Egypt Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
Figure Nigeria Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
Figure South Africa Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
Table Global Gastrointestinal Therapeutics Revenue (Million USD) by Type (2013-2018)
Table Global Gastrointestinal Therapeutics Revenue Share by Type (2013-2018)
Figure Global Gastrointestinal Therapeutics Revenue Share by Type (2013-2018)
Figure Global Gastrointestinal Therapeutics Revenue Share by Type in 2017
Table Global Gastrointestinal Therapeutics Revenue Forecast by Type (2018-2023)
Figure Global Gastrointestinal Therapeutics Market Share Forecast by Type (2018-2023)
Figure Global Oral Revenue Growth Rate (2013-2018)
Figure Global Parenteral Revenue Growth Rate (2013-2018)
Table Global Gastrointestinal Therapeutics Revenue by Application (2013-2018)
Table Global Gastrointestinal Therapeutics Revenue Share by Application (2013-2018)
Figure Global Gastrointestinal Therapeutics Revenue Share by Application (2013-2018)
Figure Global Gastrointestinal Therapeutics Revenue Share by Application in 2017
Table Global Gastrointestinal Therapeutics Revenue Forecast by Application (2018-2023)
Figure Global Gastrointestinal Therapeutics Market Share Forecast by Application (2018-2023)
Figure Global IBD Revenue Growth Rate (2013-2018)
Figure Global Irritable Bowel Syndrome (IBS) Revenue Growth Rate (2013-2018)
Figure Global Gastrointestinal Therapeutics Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Gastrointestinal Therapeutics Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Gastrointestinal Therapeutics Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Gastrointestinal Therapeutics Revenue Market Forecast (2018-2023)
Figure Europe Gastrointestinal Therapeutics Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Gastrointestinal Therapeutics Revenue Market Forecast (2018-2023)
Figure South America Gastrointestinal Therapeutics Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Gastrointestinal Therapeutics Revenue Market Forecast (2018-2023)
Figure Gastrointestinal Therapeutics Picture
Table Product Specifications of Gastrointestinal Therapeutics
Table Global Gastrointestinal Therapeutics and Revenue (Million USD) Market Split by Product Type
Figure Global Gastrointestinal Therapeutics Revenue Market Share by Types in 2017
Figure Oral Picture
Figure Parenteral Picture
Table Global Gastrointestinal Therapeutics Revenue (Million USD) by Application (2013-2023)
Figure Gastrointestinal Therapeutics Revenue Market Share by Applications in 2017
Figure IBD Picture
Figure Irritable Bowel Syndrome (IBS) Picture
Table Global Market Gastrointestinal Therapeutics Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Gastrointestinal Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Gastrointestinal Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Gastrointestinal Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Gastrointestinal Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Gastrointestinal Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Gastrointestinal Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Table AbbVie Basic Information, Manufacturing Base and Competitors
Table AbbVie Gastrointestinal Therapeutics Type and Applications
Table AbbVie Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Allergan Basic Information, Manufacturing Base and Competitors
Table Allergan Gastrointestinal Therapeutics Type and Applications
Table Allergan Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Gastrointestinal Therapeutics Type and Applications
Table Johnson & Johnson Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Takeda Basic Information, Manufacturing Base and Competitors
Table Takeda Gastrointestinal Therapeutics Type and Applications
Table Takeda Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Gastrointestinal Therapeutics Type and Applications
Table Novartis Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Gastrointestinal Therapeutics Type and Applications
Table Pfizer Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Gastrointestinal Therapeutics Type and Applications
Table Merck Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table F. Hoffmann-La Roche Basic Information, Manufacturing Base and Competitors
Table F. Hoffmann-La Roche Gastrointestinal Therapeutics Type and Applications
Table F. Hoffmann-La Roche Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Eli Lilly Basic Information, Manufacturing Base and Competitors
Table Eli Lilly Gastrointestinal Therapeutics Type and Applications
Table Eli Lilly Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Gastrointestinal Therapeutics Type and Applications
Table AstraZeneca Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Procter & Gamble Basic Information, Manufacturing Base and Competitors
Table Procter & Gamble Gastrointestinal Therapeutics Type and Applications
Table Procter & Gamble Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Tillotts Pharma Basic Information, Manufacturing Base and Competitors
Table Tillotts Pharma Gastrointestinal Therapeutics Type and Applications
Table Tillotts Pharma Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Shire Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Shire Pharmaceuticals Gastrointestinal Therapeutics Type and Applications
Table Shire Pharmaceuticals Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline Gastrointestinal Therapeutics Type and Applications
Table GlaxoSmithKline Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Amgen Basic Information, Manufacturing Base and Competitors
Table Amgen Gastrointestinal Therapeutics Type and Applications
Table Amgen Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Global Gastrointestinal Therapeutics Revenue (Million USD) by Players (2013-2018)
Table Global Gastrointestinal Therapeutics Revenue Share by Players (2013-2018)
Figure Global Gastrointestinal Therapeutics Revenue Share by Players in 2016
Figure Global Gastrointestinal Therapeutics Revenue Share by Players in 2017
Figure Global Top 5 Players Gastrointestinal Therapeutics Revenue Market Share in 2017
Figure Global Top 10 Players Gastrointestinal Therapeutics Revenue Market Share in 2017
Figure Global Gastrointestinal Therapeutics Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Gastrointestinal Therapeutics Revenue (Million USD) by Regions (2013-2018)
Table Global Gastrointestinal Therapeutics Revenue Market Share by Regions (2013-2018)
Figure Global Gastrointestinal Therapeutics Revenue Market Share by Regions (2013-2018)
Figure Global Gastrointestinal Therapeutics Revenue Market Share by Regions in 2017
Figure North America Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
Figure Europe Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
Figure South America Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
Table North America Gastrointestinal Therapeutics Revenue by Countries (2013-2018)
Table North America Gastrointestinal Therapeutics Revenue Market Share by Countries (2013-2018)
Figure North America Gastrointestinal Therapeutics Revenue Market Share by Countries (2013-2018)
Figure North America Gastrointestinal Therapeutics Revenue Market Share by Countries in 2017
Figure USA Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
Figure Canada Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
Figure Mexico Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
Table Europe Gastrointestinal Therapeutics Revenue (Million USD) by Countries (2013-2018)
Figure Europe Gastrointestinal Therapeutics Revenue Market Share by Countries (2013-2018)
Figure Europe Gastrointestinal Therapeutics Revenue Market Share by Countries in 2017
Figure Germany Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
Figure UK Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
Figure France Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
Figure Russia Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
Figure Italy Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Gastrointestinal Therapeutics Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Gastrointestinal Therapeutics Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Gastrointestinal Therapeutics Revenue Market Share by Countries in 2017
Figure China Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
Figure Japan Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
Figure Korea Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
Figure India Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
Table South America Gastrointestinal Therapeutics Revenue by Countries (2013-2018)
Table South America Gastrointestinal Therapeutics Revenue Market Share by Countries (2013-2018)
Figure South America Gastrointestinal Therapeutics Revenue Market Share by Countries (2013-2018)
Figure South America Gastrointestinal Therapeutics Revenue Market Share by Countries in 2017
Figure Brazil Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
Figure Argentina Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
Figure Colombia Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Gastrointestinal Therapeutics Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Gastrointestinal Therapeutics Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Gastrointestinal Therapeutics Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Gastrointestinal Therapeutics Revenue Market Share by Countries in 2017
Figure Saudi Arabia Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
Figure UAE Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
Figure Egypt Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
Figure Nigeria Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
Figure South Africa Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)
Table Global Gastrointestinal Therapeutics Revenue (Million USD) by Type (2013-2018)
Table Global Gastrointestinal Therapeutics Revenue Share by Type (2013-2018)
Figure Global Gastrointestinal Therapeutics Revenue Share by Type (2013-2018)
Figure Global Gastrointestinal Therapeutics Revenue Share by Type in 2017
Table Global Gastrointestinal Therapeutics Revenue Forecast by Type (2018-2023)
Figure Global Gastrointestinal Therapeutics Market Share Forecast by Type (2018-2023)
Figure Global Oral Revenue Growth Rate (2013-2018)
Figure Global Parenteral Revenue Growth Rate (2013-2018)
Table Global Gastrointestinal Therapeutics Revenue by Application (2013-2018)
Table Global Gastrointestinal Therapeutics Revenue Share by Application (2013-2018)
Figure Global Gastrointestinal Therapeutics Revenue Share by Application (2013-2018)
Figure Global Gastrointestinal Therapeutics Revenue Share by Application in 2017
Table Global Gastrointestinal Therapeutics Revenue Forecast by Application (2018-2023)
Figure Global Gastrointestinal Therapeutics Market Share Forecast by Application (2018-2023)
Figure Global IBD Revenue Growth Rate (2013-2018)
Figure Global Irritable Bowel Syndrome (IBS) Revenue Growth Rate (2013-2018)
Figure Global Gastrointestinal Therapeutics Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Gastrointestinal Therapeutics Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Gastrointestinal Therapeutics Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Gastrointestinal Therapeutics Revenue Market Forecast (2018-2023)
Figure Europe Gastrointestinal Therapeutics Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Gastrointestinal Therapeutics Revenue Market Forecast (2018-2023)
Figure South America Gastrointestinal Therapeutics Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Gastrointestinal Therapeutics Revenue Market Forecast (2018-2023)
